Overview

Megestrol Acetate Plus Metformin to Megestrol Acetate in Patients With Endometrial Atypical Hyperplasia or Early Stage Endometrial Adenocarcinoma

Status:
Completed

Trial end date:
2017-10-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to see if megestrol acetate plus metformin will be more effective in returning the endometrial tissue to a normal state than megestrol acetate alone in patients with endometrial atypical hyperplasia or early stage endometrial adenocarcinoma.

Phase:

Phase 2

Details

Lead Sponsor:

Xiaojun Chen

Collaborators:

Fudan University
Shanghai 6th People's Hospital
Shanghai Changning Maternity & Infant Health Hospital
Zhejiang Cancer Hospital

Treatments:

Megestrol
Megestrol Acetate
Metformin